Author:
Zou Lihui,Zhang Junhua,Han Jingli,Li Wenqing,Su Fei,Xu Xiaomao,Zhai Zhenguo,Xiao Fei
Funder
Beijing Natural Science Foundation
National Science and Technology Major Project for Significant New Drugs Creation
National Natural Science Foundation of China
Beijing Hospital Nova Project
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F. Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol. 2011;8(8):443–55.
2. Baliga RS, Macallister RJ, Hobbs AJ. Vasoactive peptides and the pathogenesis of pulmonary hypertension: role and potential therapeutic application. Handb Exp Pharmacol. 2013;218:477–511.
3. Zou L, Xu X, Zhai Z, Yang T, Jin J, Xiao F. Identification of downstream target genes regulated by the nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate signal pathway in pulmonary hypertension. J Int Med Res. 2016;44(3):508–19.
4. Zhang S, Zou L, Yang T, Yang Y, Zhai Z, Xiao F. The sGC activator inhibits the proliferation and migration, promotes the apoptosis of human pulmonary arterial smooth muscle cells via the up regulation of plasminogen activator inhibitor-2. Exp Cell Res. 2015;332(2):278–87.
5. Zou L, Zhang S, Xu X, Xiao F, Zhai Z. Expression of PAI-2 mRNA in peripheral blood leucocytes and regulation by sGC activator in pulmonary hypertension. Zhonghua Yi Xue Za Zhi. 2016;96(16):1247–51.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献